October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 17, 2014

Pillar Rock USA recently introduced JetRyte, a nutritional supplement formulated to combat jet lag. 

October 15, 2014

Procter & Gamble earlier this year added some heft to its Metamucil brand with a pair of line extensions that create a linear brand block.

October 14, 2014

Cardinal Health on Tuesday announced it had recently donated more than 1 million products to AmeriCares Emergency Response Program to help contain the deadly Ebola outbreak in West Africa. 

October 10, 2014

The Food and Drug Administration on Friday approved Gilead's Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus genotype 1 infection.

October 10, 2014

The National Association of Chain Drug Stores submitted a written statement in lead-up to a forum hosted by U.S. Rep. Renee Ellmers, R-N.C.

October 9, 2014

At a time when nearly every media outlet is covering Ebola, Enterovirus D-68, or a new outbreak of an infectious disease, the American Pharmacists Association is reminding Americans that the nation’s pharmacists are ready to help.

October 9, 2014

National leaders in hypertension have acknowledged PharmaSmart as the only blood pressure kiosk solution that can be “recommended by physicians” for patient monitoring, the company announced Thursday.

October 8, 2014

The dietary supplement industry on Tuesday spoke out against any supplement manufacturer making advertising claims around the Ebola virus.

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 7, 2014

GoJo on Monday announced today that it will support City of Hope, a research and treatment center for cancer, diabetes and life-threatening diseases located in Los Angeles, through a special promotion.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

October 6, 2014

Seven influenza vaccine manufacturers projected that as many as 151 million to 159 million doses of influenza vaccine will be available for use in the United States.

October 6, 2014

FloraTummys is a new probiotic especially made for kids rather than a line extension of the adult probiotic.

October 3, 2014

Biolife is helping to combat the Ebola issue with the donation of its WoundSeal product, which helps stop bleeding and seals wounds, to Africa, according to a report from ABC affiliate WWSB

 

October 2, 2014

Sam’s Club Pharmacies announced Thursday it will host free women’s health screenings to both members and non-members on Oct. 11 from 11 a.m. to 3 p.m.

October 2, 2014

Seroyal on Wednesday announced the Canadian release of Genestra Brands Statin Care, a balanced nutritional supplement formulated to provide nutritional support for patients taking statin medications.

October 1, 2014

Walgreens last month posted an aspirational video to its YouTube channel that really captures the signficance of its "Get a Shot. Give a Shot." campaign conducted in partnership with the United Nations Foundation.

September 29, 2014

Cardinal Health Specialty Solutions and KEW Group agree to make KEW's diagnostic services available to Specialty Solutions' community oncology customers.

September 23, 2014

The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people ages 6 months and older.

September 23, 2014

Sandoz announced the launch of Kerydin (tavaborole) topical solution, 5% in the United States. Kerydin is the first oxaborole antifungal for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes, the company stated. 

September 22, 2014

As the evolution of antibiotic resistance in bacteria occurs at an alarming rate, the President’s Council of Advisors on Science and Technology announced that it released to the president last week a report, called "Combating Antiboitic Resistance."

 

 

September 22, 2014

The Baltimore Convention Center this year played host to more than 23,000 attendees and 1,277 exhibitors at the 2014 Nat Expo East convention for specialty channel operators in the natural food and health space.

September 16, 2014

Baxter International announced that the Food and Drug Adminsitration approved Rixubis [coagulation factor IX (recombinant)] for the treatment, control and prevention of bleeding episodes, as well as perioperative management, in children with hemophilia B.